Beyond its remote-controlled cancer drug delivery platform and COVID-19 nanoparticle treatment, Global Cancer Technology is commercializing its technologies through wholly owned subsidiaries.
Click below to learn more about our subsidiaries.
UCN-01 for sensitizing tumors
Nano quantum dots for tracking medical instruments
‘Boiling histotripsy’ to treat cancer
Nanotechnology treatment for
COVID-19 and cancer